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Background: Several sinus floor elevation procedures for implant placement have been introduced. The present 
study aimed to evaluate the implants placed with Platelet-rich fibrin (PRF) alone in atrophic posterior maxillae and 
survival rates and the potential factors associated with implant loss. 
Material and Methods: This retrospective study evaluated 71 implants in 34 patients after 1-7 years’ follow-up 
time. Statistical models were used to determine the implant survival and the potential factors associated with loss. 
Results: Overall, 7 implants were lost, and the cumulative survival rate at 7 years by implant-based and patient-ba-
ses analyses were 85.5% and 85.7%, respectively. The mean residual bone height (RBH) was 4.26 mm. The implant 
survival rate was significantly lower at RBH < 4 mm than RBH ≥ 4 mm. 
Conclusion: This retrospective study showed that sinus floor elevation with PRF alone could be applied in cases of 
lower RBH. However, it should be carefully performed in cases of RBH < 4 mm before surgery.




In the posterior maxillary area, several sinus floor ele-
vation procedures for implant placement have been in-
troduced since the 1980s. With the development of sinus 
elevation techniques, various graft materials for sinus 
augmentation have been used as filler to maintain ade-
quate space for new bone formation. Although autoge-
nous bone is still considered the gold standard, its use 
necessarily creates another wound at the donor site, such 
as the mandibular ramus or symphysis. Autogenous bone 
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is therefore not widely used in clinical practical. Other 
graft materials, such as allogenic, xenogenic, alloplastic 
materials or combinations of different graft materials, 
have been introduced (1). However, these materials also 
have their limitations, including risk of infection, insu-
fficient bone regeneration and increased overall cost. As 
such, no graft material appears to be superior to others 
at present. 
Autologous platelet concentrates have been used for 
over 30 years and have the potential to induce wound 
healing (2). Whitmann et al. first reported the applica-
tion of platelet-rich plasma (PRP) for oral surgery pro-
cedures (3). Although several studies of PRP have been 
reported, PRP application is complicated and associated 
with risk because of the use of bovine thrombin. In con-
trast, the application of platelet-rich fibrin (PRF), deve-
loped in 2001 by Choukroun et al. as a second-genera-
tion platelet concentrate, is relatively simple, cheap and 
safe (4). Therefore, PRF has been applied for maxillary 
sinus augmentation. Previous reports have shown that 
sinus floor elevation with PRF as graft material achie-
ved favorable results. Sinus augmentation using freeze-
dried bone allograft mixed with PRF showed accelera-
ted bone regeneration and reduced healing time (5). PRF 
and bovine bone graft material combination is also more 
effective in the first phases of wound healing than bovi-
ne bone graft material and collagen membrane combina-
tion (6). Recently, the use of PRF as a sole graft mate-
rial for sinus augmentations with simultaneous implant 
placement has shown promising results. In 2008, Diss 
et al. first published the one-year results of implant pla-
cement with the osteotome technique using PRF as the 
only graft material (7). Toffler et al. showed that osteo-
tome sinus floor elevation with PRF was extremely safe 
and successful at sites 5- to 8 mm residual bone height 
(RBH) (8). However, the longer-term outcomes of the 
procedure and failure factors have not been sufficiently 
examined. The aim of this retrospective study was to test 
the null hypothesis that there is no difference in failure 
factors for implants inserted with PRF as the only graf-
ting material for sinus augmentation.     
Material and Methods
-Study design and patient selection
A retrospective study design was employed. The study 
protocol was approved by the Ethics Committee  (No. 
46-10-0004). The clinical procedures were performed 
in accordance with the Helsinki Declaration (revised in 
2008), and all patients signed the informed consent for-
ms before treatment. 
The patients treated sinus floor augmentation using PRF 
as the sole grafting material at , from September 2010 to 
October 2015 were screened in this study. The patients’ 
medical and dental histories were checked at the initial 
appointment, and patients were then selected based on 
following criteria: 1) tooth loss in the maxillary poste-
rior region, 2) good general health or controlled medical 
conditions, 3) implant placement by sinus floor eleva-
tion with PRF alone as the grafting material, 4) informed 
consent provided and 5) follow-up visit performed after 
implant placement at our hospital. 
-Surgical and prosthetic procedure
Panoramic radiography and computer tomography (CT) 
were performed to examine the bone and sinus condi-
tions. Surgery was performance under local anesthesia. 
A midcrestal incision was made, and the buccal and 
palatal mucoperiosteal flaps were reflected using a fu-
ll-thickness approach to expose the posterior maxillary 
edentulous area. For the crestal approach, implant holes 
were drilled using the CAS-KIT (OSSTEM Implant Co., 
Busan, Korea). In accordance with the manufacturer’s 
guideline, the CAS-drill must be used with a stopper. 
Once the drill tip reached the Schneiderian membrane, 
saline was slowly injected into the prepared hole with 
pumping to detach the Schneiderian membrane by hy-
draulic pressure using a hydraulic membrane lifter 
(OSSTEM Implant Co., Busan, Korea). PRF clots were 
compressed into a thin membrane in accordance with 
the protocol of Choukroun et al. (5) and multiple PRF 
membranes were inserted into the sinus floor elevated 
site. Implants were inserted simultaneously. For the la-
teral approach, full-thickness flaps were elevated after 
a midcrestal incision was made. A lateral window via 
the buccal maxillary wall was created using the LAS-
KIT (OSSTEM Implant Co., Busan, Korea). After ca-
reful elevation of the Schneiderian membrane, the bone 
window served as a new sinus floor. Two or three PRF 
clots were inserted into the sinus cavity. The implant 
sites were prepared with careful drilling, and then the 
implants were inserted. Finally, the PRF membrane was 
used to cover bony window site. 
Furthermore, when performing a lateral approach to si-
nus floor elevation for delayed implant placement, a fu-
ll-thickness mucoperiosteal flap was elevated, and then 
the lateral maxillary wall was carefully removed and the 
Schneiderian membrane was elevated with sinus cure-
ttes. After the intact sinus cavity was created, three or 
four PRF clots were inserted into the new sinus cavi-
ty. PRF membrane was used to cover the bony window 
site, and the flaps were sutured. After an approximately 
three-month healing period, implants were placed using 
the crestal approach. Three different sinus floor eleva-
tion procedures which are simultaneously carried out 
with the crestal and lateral approach, and staged implant 
placement were classified in this study. After the healing 
period, implant-supported supra-structures, including 
single crowns, fixed partial denture and overdentures, 
were fabricated and delivered to the patients.             
-Outcome measurements
• The implant survival
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The implant survival criteria suggested by Buser et al. 
(9) were adopted, as follows: 1) the absence of implant 
mobility, 2) the absence of pain or any subjective sensa-
tion, 3) the absence of recurrent peri-implant infection 
and 4) the absence of continuous radiolucency around 
the implants. Implant failure was classified into two 
groups: early failure before loading, and late failure after 
loading (10). The implant survival rate was calculated 
by measuring the time elapsed from implant placement 
to the last follow-up visit or implant removal.
• Radiographic assessment
Radiographic assessments were conducted on CT ima-
ges using a software program (Simplant, Dentsply, 
MA, USA) on a millimeter scale. Radiographs were 
analyzed by one examiner (MS). Before surgery, the 
RBH at the radiographic guides with a marker site was 
determined. 
-Statistical analyses
The implant survival rate analyzed using the Kaplan-
Meier curve. A logistic regression analysis was use to 
investigate the potential factors influencing implant loss. 
The independent factors were sex, age, smoking status, 
site (premolar or molar), and implant length (< 10 or ≥ 
10 mm). The SPSS 17.0 software program (SPSS Inc., 
Chicago, IL, USA) was used to perform all statistical 
analyses, and the significance level was set to p < 0.05. 
Results
-Patient and implant information
Between September 2011 and October 2015, a total of 34 
patients (17 male and 17 female), aged 29 to 82 years old 
(mean age 57.6), underwent sinus augmentation by PRF 
alone in this study. The average follow-up time was 3.43 
years. The patients were treated with 71 implants inserted 
into 19 premolars and 52 molars. The implants were as 
follows: 21 POIEX implants, 3.7 to 5.2 mm in diameter 
and 8 to 10 mm in length (KYOCERA Medical, Osaka, 
Japan); 45 TSIII implants, 4.0 to 5.0 mm in diameter and 
8.5 to 11.5 mm in length (OSSTEM Implant Co., Busan, 
Korea); 4 USIII implants, 4.0 to 5.0 mm in diameter and 
8.5 to 11.5 mm in length (OSSTEM Implant Co., Busan, 
Korea); 1 GSIII implant, 4.5 mm in diameter and 10 mm 
in length (OSSTEM Implant Co., Busan, Korea).
Fifty-four implants were placed simultaneously via the 
crestal approach, and 15 were placed simultaneously via 
the lateral approach. Two implants in one patient were 
placed via the staged approach. The distributions of pa-
tient and implant are presented in Table 1. 
-The implant survival and failures
After 1-7 years follow-up, seven implants in four pa-
tients were lost. The cumulative survival rates were 
85.5% by implant-based analysis and 85.7% by pa-
tient-based analysis Table 2. Moreover, the cumulative 
survival rates were 100% and 69.6% for the RBH ≥ 4 
mm group and the RBH < 4 mm group, respectively 
(Log-rank test: p = 0.004) Figure 1. The details regar-
ding the lost implants are shown in Table 3. Among the 
seven lost implants, four implants in two patients were 
lost two years after placement. One of them was remo-
ved and replaced with sinus augmentation by PRF alone. 
Another three implants in two patients were lost before 
prosthetic loading.    
-Radiographic assessments
The mean RBH before implant placement as measured 
in the radiographs was 4.26 ± 2.11 mm and ranged from 
0.56 to 9.60 mm in this study. 
-Logistic regression analysis of risk indicators for im-
plant loss
Logistic regression for determining the factors affecting 
implant loss are showed in Table 4. However, implant 
loss was found for male patients (OR, 2.4) and implant 
length< 10 mm (OR, 7.3), none of the factors was found 
be significantly related to implant loss.
Discussion
Various sinus augmentation procedures have been in-
troduced to overcome the insufficient bone height for 
implant placement in the posterior maxillae. The pro-
cedures with platelet concentrates have been developed. 
PRP has been widely used as bone graft material in sinus 
augmentation procedures. However, Lemos et al. found 
that PRP with bone graft appeared to have no influence 
on bone formation or the implant survival in maxillary 
sinus augmentation (11). Furthermore, preparation for 
PRP is relatively complex, and there are potential risks 
with this material, as PRP contains synthetic or anticoa-
gulant materials. Therefore, the actual efficacy of PRP 
is controversial, although it has the ability to release va-
rious growth factors to enhance bone regeneration.
PRF has several advantages over PRP, including easier 
preparation and lower cost (6). In addition, although 
the in vitro conditions do not fully reflect the clinical 
situation, the biological characteristics of PRF are also 
superior to PRP (12). Accordingly, there have been some 
published clinical reports of sinus floor elevation using 
PRF as grafting material (5,7,8,13). Choukroun et al re-
ported sinus floor augmentation using PRF in combina-
tion with a freeze-dried bone allograft (5). In that report, 
the mixed graft material was able to reduce the healing 
time. Tanaka et al. also described increased new bone 
formation in the histological evaluation of sinus aug-
mentation with deproteinized bovine bone mixed with 
PRF (14). However, combination with these particulate 
bone materials has been associated with increased costs 
and risk of infection. Accordingly, sinus floor elevation 
using PRF as the sole graft material has been recent-
ly introduced. Diss et al. reported the survival rate at 
1 year after sinus floor elevation with PRF as the sole 
graft material based on 20 patients and 35 implants (7). 
Subsequently, Toffler reported the survival rate of 138 





Male          Female 
17             17 
Age at implant placement <40    40-50    51-60    61-70       70< 
2       3       11       14         4 
Underlying disease* Diabetes      Hypertension     Digestive disease 
   7              4                 3 
Ischemic disease   Respiratory disease     Others 
      2               1               13 
Number of smoker 7 
Total number of implant placed 71 
Implant placement sites Premolar      Molar 
19          52 
Residual bone height <2 mm   2-3 mm   3-4 mm   4-5 mm   5 mm< 
8       15       12        11       25 
Implant length 8 mm     8.5 mm     10 mm     11.5 mm 
6         28         34         3 
Implant diameter 3.7 mm 4.0 mm 4.2 mm 4.5mm 4.7 mm 5.0 mm 5.2 mm 
2      18     17    8      8     15     3 
Surgical technique 
 
Crestal approach   Lateral approach   Two-staged approach 
54              15                  2 
Healing time 
for the loading implants 
< 90 days     90-180 days     180days< 
3            31            35 
Prosthetic type Crown   Fixed bridge   Removal partial denture 
        55         13                 3 
Table 1: Distribution of patients and implants.
*includes multiple responses
implants in 110 patients at less than 12 months after pla-
cement using a similar procedure (8). These survival ra-
tes were 97.1% and 97.8%, respectively (7,8). 
The present retrospective study evaluated the outcomes 
of 71 implants in 34 patients treated with sinus aug-
mentation with PRF alone after 1-7 years’ follow-up. 
A 7-year cumulative survival rate of about 85.5% was 
detected. This result was slightly lower than the values 
described by Diss and Toffler (7,8). However, in those 
two studies, the follow-up duration from implant place-
ment was shorter (one year or less) than in the present 
study. Furthermore, the mean RBH differed from the 
present study (6.5 and 6.6 mm, respectively, in Diss and 
Toffler’s studies, and 4.3 mm in the present study). For 
implants placed using sinus floor elevation, the survival 
rate is affected by the preexisting bone height between 
the sinus floor and crest (15). Therefore, the lower survi-
val rate of the present study than these reports was affec-
ted by the RBH. 
Grafting bone materials, such as a xenograft, help to 
maintain the membrane in an elevated position, since 
they have strong physical properties (16). While whe-
ther or not PRF can maintain the membrane in an ele-
vated position is unclear, since they have softer physical 
properties. Therefore, the volume and the form of PRF 
placed into sinus cavity might make it difficult to main-
tain an elevated membrane position. The elevated mem-
brane position sequentially drops down to the implant 




(year) Implant numbers Failure numbers
Cumulative survival rates
(%)
0-1 71 3 95.8
1-2 68 0 95.8
2-3 55 2 91.8
3-4 45 2 85.5
4-5 27 0 85.5
5-6 9 0 85.5
6-7 3 0 85.5
Patient-based analysis 
Time interval
(year) Patient numbers Failure numbers
Cumulative survival rates
(%)
0-1 34 2 94.1
1-2 32 0 94.1
2-3 25 2 85.7
3-4 20 0 85.7
4-5 11 0 85.7
5-6 4 0 85.7
6-7 2 0 85.7
Table 2: The cumulative survival rate of implant- and patient-based analysis.
Fig. 1: Kaplan-Meier survival curves for RBH ≥ 4 mm and RBH < 4 mm by an implant-based analy-
sis. RBH: Residual bone height.
apex. The implant is similar in appearance to a tent pole. 
However, Kanayama et al. found that membranes eleva-
ted using PRF alone were able to maintain a higher po-
sition above the implant apex, a result which may have 
been influenced by many factors, including the shape of 
the sinus cavity, the presence or absence of adjacent tee-
th and other factors (17). 
A logistic analysis was performed to investigated the 
factors associated with implant loss. There were no sig-
nificant differences in the sex, age, smoking status, pla-
cement site or implant length between cases of failure 
and success. A previous study reported on the relations-
hip between RBH and implant failure/success with the 
sinus floor elevation procedure (15,18,19). Del Fabbro 











technique** Time of lost
Lost 
type***
































4 F/37 25 3.87 C 8.2 Early
Table 3: The details of the lost implant.
*RBH: Residual bone height       **C: Crestal approach    
***Lost type: Early is lost within the healing period after implant placement
Late is lost after loading  
Parameter Survival Lost Odds ration 95%CI p-Value
Sex    Male








Age    >60


















Site   Molar









     < 10 mm








Table 4: Logistic regression for determining the factors affecting implant loss after sinus augmentation with Platelet-rich fibrin alone.
CI: confident interval
also described a favorable prognosis when the RBH was 
at least 5 mm (18). A study by Toffler using a similar pro-
cedure with PRF also described a decreased survival rate 
when RBH was <5 mm (19). Rosen found that the survi-
val rate decreased to 85.7% when RBH was ≤ 4 mm.15 
These results suggest a potentially favorable prognosis 
with a line of demarcation between RBH of 4 or 5 mm. 
Therefore, we classified subjects into two groups (RBH 
≥ 4 mm and < 4 mm) and investigated the survival rate. 
When RBH was ≥ 4 mm, the survival rate was 100%. In 
contrast, when RBH was < 4 mm, the survival rate dro-
pped to 69.6%. Furthermore, the Therefore, RBH also 
affects the survival of the implant when sinus augmenta-
tion with PRF alone is applied. Implant loss in cases of 
lower RBH occurs due to difficulty in acquiring implant 
stability. In addition, three of the four cases of loss in the 
present study were found to have smoking and bruxism, 
factors that may be associated with an increased risk of 
implant loss (20,21). 
Lundgren et al. first suggested the placement of implants 
without the addition of any grafting materials (22). Fur-
thermore, four randomized clinical trials and a systema-
tic review for a procedure without bone graft have also 
been reported and indicated favorable outcomes, such as 
solicitude regarding remaining graft particles and redu-
ced rates of complications and lower costs (10,23-25). 
However, this graft-free procedure still remains con-
troversial. Nedir showed that sites with RBH < 4 mm 
allowed implant placement without the use of grafting 
materials, although a greater amount of new bone for-
mation was gained when grafting materials were used 
(26). However, in the present study, all cases of failure 
showed RBH < 4 mm. Therefore, to evaluate how many 
millimeters of RBH are required without grafting ma-
terials, larger samples and longer-term observations are 
still needed. 
Regarding the advantage of using PRF over procedures 
without grafting materials, PRF could enhance bone ge-
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neration (27). Perforation of the Schneiderian membra-
ne is the most common complication in sinus grafting 
procedures, occurring in 10% to 60% of cases (28,29). 
We believe that PRF presents a great advantage with res-
pect to protecting the membrane from perforation when 
placing implants, acting as a kind of “barrier material”. 
During implant placement without graft materials, there 
is some possibility of the implant apex perforating the 
membrane after elevating sinus floor. Since the crestal 
approach for sinus floor elevation is a blind procedure and 
it is difficult to confirm whether or not perforation has oc-
curred, the use of any graft materials might not be favora-
ble. PRF also affects membrane repair if sinus membrane 
perforations occur during the sinus lift procedure (7,30). 
The present study included a two-stage approach with 
PRF alone. PRF as a grafting material is responsible for 
maintaining the Schneiderian membrane position. PRF 
is absorbed gradually, so PRF as the sole filling material 
without simultaneous implant placement may not be ade-
quate for maintaining the membrane. However, our pre-
vious report disputes this notion (13). That report showed 
that PRF clots alone can create space between the origi-
nal sinus floor and the elevated Schneiderian membrane. 
The volume of PRF may be important for maintaining the 
membrane. Therefore, PRF clots may be more useful than 
a PRF membrane. However, the two-stage protocol has 
several limitations, like a relatively short follow-up pe-
riod. Further studies are therefore needed to obtain stron-
ger evidence to confirm our findings.
Conclusion
This 1- to 7-year retrospective study showed that sinus 
floor elevation with PRF alone is a safe procedure be-
cause PRF was able to protect the membrane during im-
plant installation and thereby avoid any perforation of 
the membrane. The procedure provides favorable results 
when the RBH is low. However, the risk of implant loss 
increases when RBH is < 4 mm. These findings suggest 
that long-term follow-up and a large sample are required 
to confirm the predictability of this procedure. 
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